Application no. and date | 10179104.4 (espacenet) (Federated) (European Patent Register), 20010803 | Patent/reg. no. and date | DK/EP 2348032, 20150715 | Publication date | 20110727 | Priority no. and date | GB 0019172, 20000805, GB 0108800, 20010407 | EP pub. no. and date |
EP 2348032 20110727 | Effective date | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | 159058 | Inventor | Biggadike, Keith, GlaxoSmithKline Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY, GB, Coote, Steven, John, GlaxoSmithKline Gunnells Wood Road
Stevenage, Hertfordshire SG1 2NY, GB, Nice, Rosalyn, Kay, c/o GlaxoSmithKline, 9890 Great West Road,
Brentford, Middlesex, TW8 9GS, GB | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/58 (2006.01) , A61P 5/44 (2006.01) , C07J 31/00 (2006.01) | Title | 6.Alpha.,9.alpha.-difluor-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-dien-17-carbothiotinsyre s-fluoromethylester som et anti-inflammatorisk middel. | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|